As compared with Control samples, HAVCR2 and LAG3 expression levels were significantly higher in male AD samples at 9.978 and 8.373 (P = 0.012 and 0.041; Wilcoxon rank sum test). The gene discussed is LAG3; the disease is Alzheimer disease.